AngioDynamics Turns To Profit In Q3; Lifts FY14 Revenue Outlook - Quick Facts

(RTTNews) - AngioDynamics Inc. (ANGO) Wednesday said third-quarter net income was $5.1 million or $0.14 per share, compared to net loss of $992 thousand or $0.03 per share in the same period last year.

Adjusted earnings for the quarter was $5.6 million or $0.16 per share. On average, four analysts polled by Thomson Reuters expected the company to earn $0.09 per share for the quarter.

Sales totaled $88.20 million, up 8% from $81.57 million last year, while four analysts expected sales of $86.85 million.

Looking ahead to the fourth quarter, the company has forecast earnings in the range of $0.18 to $0.21 per share, with revenues ranging between $91 million and $95 million. Analysts currently expect the company to earn $0.14 per share on fourth-quarter revenues of $93.17 million.

For the fiscal 2014, the company now expects earnings in the range of $0.60 to $0.63 per share, down from its previous range of $0.63 to $0.67 per share. Analysts currently expect earnings of $0.33 per share.

The company raised its revenue to a range of $351 million to $355 million from its prior range of $349 million to $353 million. Analysts currently expect full-year revenues of $352.20 million.